vs
Side-by-side financial comparison of ASTROTECH Corp (ASTC) and HARVARD BIOSCIENCE INC (HBIO). Click either name above to swap in a different company.
HARVARD BIOSCIENCE INC is the larger business by last-quarter revenue ($23.7M vs $148.0K, roughly 160.4× ASTROTECH Corp). HARVARD BIOSCIENCE INC runs the higher net margin — -12.0% vs -2653.4%, a 2641.4% gap on every dollar of revenue. On growth, HARVARD BIOSCIENCE INC posted the faster year-over-year revenue change (-3.3% vs -43.3%). HARVARD BIOSCIENCE INC produced more free cash flow last quarter ($-545.0K vs $-4.0M). Over the past eight quarters, ASTROTECH Corp's revenue compounded faster (72.0% CAGR vs -1.6%).
Astrotech Corporation, formerly Spacehab Inc., is a technology incubator headquartered in Austin, Texas. Astrotech uses technology sourced internally and from research institutions, government laboratories, and universities to fund, manage and sell start-up companies. Astrotech Corporation's subsidiaries provide commercial products and services to NASA, the U.S. Department of Defense, national space agencies, and global commercial customers.
Harvard Bioscience is a global developer, manufacturer and marketer of life sciences equipment to support research and drug discovery. It is traded on NASDAQ under the stock symbol HBIO.
ASTC vs HBIO — Head-to-Head
Income Statement — Q2 2026 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $148.0K | $23.7M |
| Net Profit | $-3.9M | $-2.8M |
| Gross Margin | 5.4% | 59.7% |
| Operating Margin | -2635.8% | 7.2% |
| Net Margin | -2653.4% | -12.0% |
| Revenue YoY | -43.3% | -3.3% |
| Net Profit YoY | 2.0% | -15916.7% |
| EPS (diluted) | — | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $148.0K | $23.7M | ||
| Q3 25 | $297.0K | $20.6M | ||
| Q2 25 | $220.0K | $20.4M | ||
| Q1 25 | $534.0K | $21.8M | ||
| Q4 24 | $261.0K | $24.6M | ||
| Q3 24 | $34.0K | $22.0M | ||
| Q2 24 | $74.0K | $23.1M | ||
| Q1 24 | $50.0K | $24.5M |
| Q4 25 | $-3.9M | $-2.8M | ||
| Q3 25 | $-3.5M | $-1.2M | ||
| Q2 25 | $-2.9M | $-2.3M | ||
| Q1 25 | $-3.6M | $-50.3M | ||
| Q4 24 | $-4.0M | $18.0K | ||
| Q3 24 | $-3.3M | $-4.8M | ||
| Q2 24 | $-3.0M | $-2.9M | ||
| Q1 24 | $-3.2M | $-4.7M |
| Q4 25 | 5.4% | 59.7% | ||
| Q3 25 | 63.3% | 58.4% | ||
| Q2 25 | 33.6% | 56.4% | ||
| Q1 25 | 44.4% | 56.0% | ||
| Q4 24 | 59.4% | 57.1% | ||
| Q3 24 | 26.5% | 58.1% | ||
| Q2 24 | 37.8% | 57.2% | ||
| Q1 24 | 16.0% | 60.3% |
| Q4 25 | -2635.8% | 7.2% | ||
| Q3 25 | -1190.6% | 1.0% | ||
| Q2 25 | -1326.4% | -4.0% | ||
| Q1 25 | -724.2% | -228.1% | ||
| Q4 24 | -1655.6% | 0.0% | ||
| Q3 24 | -10670.6% | -8.5% | ||
| Q2 24 | -4518.9% | -9.0% | ||
| Q1 24 | -7066.0% | -9.3% |
| Q4 25 | -2653.4% | -12.0% | ||
| Q3 25 | -1166.7% | -6.0% | ||
| Q2 25 | -1331.8% | -11.2% | ||
| Q1 25 | -680.3% | -231.2% | ||
| Q4 24 | -1536.0% | 0.1% | ||
| Q3 24 | -9641.2% | -21.9% | ||
| Q2 24 | -3998.6% | -12.7% | ||
| Q1 24 | -6308.0% | -19.1% |
| Q4 25 | — | $-0.06 | ||
| Q3 25 | — | $-0.03 | ||
| Q2 25 | — | $-0.05 | ||
| Q1 25 | — | $-1.14 | ||
| Q4 24 | — | $0.01 | ||
| Q3 24 | — | $-0.11 | ||
| Q2 24 | — | $-0.07 | ||
| Q1 24 | — | $-0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.0M | $8.6M |
| Total DebtLower is stronger | — | $35.9M |
| Stockholders' EquityBook value | $15.5M | $13.7M |
| Total Assets | $19.7M | $80.1M |
| Debt / EquityLower = less leverage | — | 2.61× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $7.0M | $8.6M | ||
| Q3 25 | $11.3M | $6.8M | ||
| Q2 25 | $15.1M | $7.4M | ||
| Q1 25 | $18.1M | $5.5M | ||
| Q4 24 | $21.5M | $4.1M | ||
| Q3 24 | $21.8M | $4.6M | ||
| Q2 24 | $42.9M | $4.0M | ||
| Q1 24 | $52.4M | $4.3M |
| Q4 25 | — | $35.9M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $34.9M | ||
| Q1 25 | — | $36.4M | ||
| Q4 24 | — | $37.0M | ||
| Q3 24 | — | $34.9M | ||
| Q2 24 | — | $35.7M | ||
| Q1 24 | — | $35.6M |
| Q4 25 | $15.5M | $13.7M | ||
| Q3 25 | $19.1M | $14.1M | ||
| Q2 25 | $22.1M | $15.7M | ||
| Q1 25 | $24.8M | $14.8M | ||
| Q4 24 | $28.1M | $63.3M | ||
| Q3 24 | $32.1M | $65.3M | ||
| Q2 24 | $34.8M | $67.2M | ||
| Q1 24 | $37.6M | $68.8M |
| Q4 25 | $19.7M | $80.1M | ||
| Q3 25 | $23.2M | $78.0M | ||
| Q2 25 | $27.0M | $80.1M | ||
| Q1 25 | $27.5M | $79.8M | ||
| Q4 24 | $31.0M | $126.6M | ||
| Q3 24 | $34.4M | $131.2M | ||
| Q2 24 | $37.6M | $128.9M | ||
| Q1 24 | $40.2M | $133.2M |
| Q4 25 | — | 2.61× | ||
| Q3 25 | — | 2.41× | ||
| Q2 25 | — | 2.22× | ||
| Q1 25 | — | 2.45× | ||
| Q4 24 | — | 0.58× | ||
| Q3 24 | — | 0.53× | ||
| Q2 24 | — | 0.53× | ||
| Q1 24 | — | 0.52× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-3.5M | $-96.0K |
| Free Cash FlowOCF − Capex | $-4.0M | $-545.0K |
| FCF MarginFCF / Revenue | -2671.6% | -2.3% |
| Capex IntensityCapex / Revenue | 277.7% | 1.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-14.9M | $5.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-3.5M | $-96.0K | ||
| Q3 25 | $-3.9M | $1.1M | ||
| Q2 25 | $-2.4M | $2.8M | ||
| Q1 25 | $-3.9M | $3.0M | ||
| Q4 24 | $-3.0M | $1.7M | ||
| Q3 24 | $-3.7M | $-842.0K | ||
| Q2 24 | $-2.5M | $-846.0K | ||
| Q1 24 | $-2.3M | $1.4M |
| Q4 25 | $-4.0M | $-545.0K | ||
| Q3 25 | $-4.4M | $877.0K | ||
| Q2 25 | $-2.7M | $2.7M | ||
| Q1 25 | $-3.9M | $2.5M | ||
| Q4 24 | $-3.4M | $1.4M | ||
| Q3 24 | $-3.9M | $-1.7M | ||
| Q2 24 | $-2.8M | $-1.7M | ||
| Q1 24 | $-2.5M | $758.0K |
| Q4 25 | -2671.6% | -2.3% | ||
| Q3 25 | -1476.1% | 4.3% | ||
| Q2 25 | -1231.4% | 13.0% | ||
| Q1 25 | -728.1% | 11.4% | ||
| Q4 24 | -1288.5% | 5.8% | ||
| Q3 24 | -11408.8% | -7.8% | ||
| Q2 24 | -3728.4% | -7.2% | ||
| Q1 24 | -5036.0% | 3.1% |
| Q4 25 | 277.7% | 1.9% | ||
| Q3 25 | 150.8% | 1.0% | ||
| Q2 25 | 158.2% | 0.4% | ||
| Q1 25 | 5.1% | 2.4% | ||
| Q4 24 | 122.2% | 1.2% | ||
| Q3 24 | 567.6% | 4.0% | ||
| Q2 24 | 305.4% | 3.5% | ||
| Q1 24 | 352.0% | 2.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 95.83× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTC
Segment breakdown not available.
HBIO
| Instruments Equipment Software And Accessories | $21.6M | 91% |
| Service Maintenance And Warranty Contracts | $2.1M | 9% |
